 NORCROSS, Ga., April 27, 2021 GLOBE NEWSWIRE -- Galectin Therapeutics Inc. NASDAQ:GALT, the leading developer of therapeutics that target galectin proteins, today announced that Pol F. Boudes, M.D., Chief Medical Officer , will present the belapectin program at the 4th Global NASH Congress taking place virtually on April 28 and 29, 2021. 